Utilization of cervical cancer screening and determinant factors among female nurses in selected public hospitals in Addis Ababa, Ethiopia

Q3 Medicine
Winta Tesfaye , Bezawit Ashine , Yadelew Yimer , Yibeltal Yismaw , Gedamnesh Bitew , Tseganesh Asefa , Kirubel Girmay , Habtu Kifle Negash , Yitbarek Fantahun Marye , Hiwot Tezera
{"title":"Utilization of cervical cancer screening and determinant factors among female nurses in selected public hospitals in Addis Ababa, Ethiopia","authors":"Winta Tesfaye ,&nbsp;Bezawit Ashine ,&nbsp;Yadelew Yimer ,&nbsp;Yibeltal Yismaw ,&nbsp;Gedamnesh Bitew ,&nbsp;Tseganesh Asefa ,&nbsp;Kirubel Girmay ,&nbsp;Habtu Kifle Negash ,&nbsp;Yitbarek Fantahun Marye ,&nbsp;Hiwot Tezera","doi":"10.1016/j.ctarc.2024.100815","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Cervical cancer is one of the top cause of death among childbearing women globally and public health issue for underdeveloped nations.It is the world's second most prevalent cancer among women. In 2018, 311,000 women died due to cervical cancer.Approximately 80 % of these deaths occurred in developing countries.However, there has been insufficient research on cervical cancer screening utilisation among Ethiopian nurses, despite the fact that nurses promote women's health and play a key role in cervical cancer education. As a result, evaluating utilization of cervical cancer screening among nurses is critical for program effectiveness.</p></div><div><h3>Objective</h3><p>To assess the magnitude of utilization of cervical cancer screening and determinant factors among female Nurses in selected public hospitals in Addis Ababa, Ethiopia.</p></div><div><h3>Methodology</h3><p>An institutional-based cross-sectional study design was employed from October 1 to November 30, 2022. Data was collected using an interviewer-administered questionnaire. The data was entered into Epi data version 3.1 and then exported to SPSS version 22 for data management and analysis. Bivariate and multi-variable logistic regressions were employed to identify the predictor variables. Statistical significance was considered at <em>P</em> &lt; 0.05 with adjusted odds ratio calculated at 95 % CI.</p></div><div><h3>Result</h3><p>The magnitude of utilization of cervical cancer screening among nurses working in selected public hospitals in Addis Ababa was 18.5 % (95 % CI: 14.2, 23.1). Having work experience &gt; 8 years (AOR = 16.78; 95 % CI: 4.82, 58.44), history of STI (AOR = 53.72; 95 % CI: 14.18, 203.45) and having multiple sexual partners (AOR = 12.74; 95 % CI: 4.15, 39.11) were significantly associated with utilization of cervical cancer screening among female nurses.</p></div><div><h3>Conclusion</h3><p>The overall cervical cancer screening rate among female nurses was low compared to the WHO strategy for cervical cancer elimination, which asks for 70 % of women worldwide to be checked for cervical illnesses regularly by 2030. According to the study findings, respondents' work experience, STI history, and having multiple sexual partners influenced their utilization of cervical cancer screening among nurses. To boost the utilization of screening services, female nurses should place a strong emphasis on maintaining screening awareness through education and knowledge sharing.Finally, we recommend future researchers to do comparative study design to draw any scientific and credible conclusions.</p></div>","PeriodicalId":9507,"journal":{"name":"Cancer treatment and research communications","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2468294224000273/pdfft?md5=4bbc3cd85d88c499dfcf879c076d155d&pid=1-s2.0-S2468294224000273-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer treatment and research communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468294224000273","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Cervical cancer is one of the top cause of death among childbearing women globally and public health issue for underdeveloped nations.It is the world's second most prevalent cancer among women. In 2018, 311,000 women died due to cervical cancer.Approximately 80 % of these deaths occurred in developing countries.However, there has been insufficient research on cervical cancer screening utilisation among Ethiopian nurses, despite the fact that nurses promote women's health and play a key role in cervical cancer education. As a result, evaluating utilization of cervical cancer screening among nurses is critical for program effectiveness.

Objective

To assess the magnitude of utilization of cervical cancer screening and determinant factors among female Nurses in selected public hospitals in Addis Ababa, Ethiopia.

Methodology

An institutional-based cross-sectional study design was employed from October 1 to November 30, 2022. Data was collected using an interviewer-administered questionnaire. The data was entered into Epi data version 3.1 and then exported to SPSS version 22 for data management and analysis. Bivariate and multi-variable logistic regressions were employed to identify the predictor variables. Statistical significance was considered at P < 0.05 with adjusted odds ratio calculated at 95 % CI.

Result

The magnitude of utilization of cervical cancer screening among nurses working in selected public hospitals in Addis Ababa was 18.5 % (95 % CI: 14.2, 23.1). Having work experience > 8 years (AOR = 16.78; 95 % CI: 4.82, 58.44), history of STI (AOR = 53.72; 95 % CI: 14.18, 203.45) and having multiple sexual partners (AOR = 12.74; 95 % CI: 4.15, 39.11) were significantly associated with utilization of cervical cancer screening among female nurses.

Conclusion

The overall cervical cancer screening rate among female nurses was low compared to the WHO strategy for cervical cancer elimination, which asks for 70 % of women worldwide to be checked for cervical illnesses regularly by 2030. According to the study findings, respondents' work experience, STI history, and having multiple sexual partners influenced their utilization of cervical cancer screening among nurses. To boost the utilization of screening services, female nurses should place a strong emphasis on maintaining screening awareness through education and knowledge sharing.Finally, we recommend future researchers to do comparative study design to draw any scientific and credible conclusions.

埃塞俄比亚亚的斯亚贝巴部分公立医院女护士利用宫颈癌筛查的情况及决定因素
背景宫颈癌是全球育龄妇女的首要死因之一,也是不发达国家的公共卫生问题。2018 年,有 31.1 万名妇女死于宫颈癌,其中约 80% 发生在发展中国家。然而,尽管护士促进妇女健康并在宫颈癌教育中发挥着关键作用,但有关埃塞俄比亚护士宫颈癌筛查利用率的研究却不足。因此,评估护士对宫颈癌筛查的利用率对于提高计划的有效性至关重要。方法 在 2022 年 10 月 1 日至 11 月 30 日期间,采用基于机构的横断面研究设计。数据收集采用访谈者发放问卷的方式。数据输入 Epi data 3.1 版,然后导出到 SPSS 22 版进行数据管理和分析。采用二元和多变量逻辑回归来确定预测变量。结果在亚的斯亚贝巴选定公立医院工作的护士中,宫颈癌筛查的使用率为 18.5%(95 % CI:14.2,23.1)。工作年限超过 8 年(AOR = 16.78;95 % CI:4.82,58.44)、性传播感染史(AOR = 53.72;95 % CI:14.18,203.45)和有多个性伴侣(AOR = 12.74;95 % CI:4.15,39.11)与女护士接受宫颈癌筛查有显著相关性。结论与世界卫生组织消除宫颈癌战略(该战略要求到 2030 年全球 70% 的妇女定期接受宫颈疾病检查)相比,女护士的总体宫颈癌筛查率较低。研究结果表明,受访者的工作经验、性传播感染史和有多个性伴侣会影响她们对护士宫颈癌筛查的利用率。为了提高筛查服务的利用率,女护士应通过教育和知识分享来强调保持筛查意识。最后,我们建议未来的研究人员进行比较研究设计,以得出科学可信的结论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.30
自引率
0.00%
发文量
148
审稿时长
56 days
期刊介绍: Cancer Treatment and Research Communications is an international peer-reviewed publication dedicated to providing comprehensive basic, translational, and clinical oncology research. The journal is devoted to articles on detection, diagnosis, prevention, policy, and treatment of cancer and provides a global forum for the nurturing and development of future generations of oncology scientists. Cancer Treatment and Research Communications publishes comprehensive reviews and original studies describing various aspects of basic through clinical research of all tumor types. The journal also accepts clinical studies in oncology, with an emphasis on prospective early phase clinical trials. Specific areas of interest include basic, translational, and clinical research and mechanistic approaches; cancer biology; molecular carcinogenesis; genetics and genomics; stem cell and developmental biology; immunology; molecular and cellular oncology; systems biology; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; cancer policy; and integration of various approaches. Our mission is to be the premier source of relevant information through promoting excellence in research and facilitating the timely translation of that science to health care and clinical practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信